Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study
by
Nickel M, Moleda D, Loew T, Rother W, Pedrosa Gil F.
Clinic for Psychosomatic,
Inntalklinik, Simbach/Inn, Germany.
m.nickel@inntalklinik.de
Int J Impot Res. 2007 Jan-Feb;19(1):104-7.


ABSTRACT

The effectiveness of cabergoline in 50 men with psychogenic erectile dysfunction was investigated in a 4-month, randomized, placebo-controlled, double-blind study with validated psychological tests, and prolactin, follicle-stimulating hormone, luteinizing hormone and testosterone serum levels. Cabergoline treatment was well-tolerated and resulted in normalization of hormone levels in most cases. In the cabergoline-treated group, significant interactions between prolactin and testosterone serum concentrations were observed. Erectile function improved significantly. Sexual desire, orgasmic function, and the patient's and his partner's sexual satisfaction were also enhanced. Cabergoline may be an effective and safe alternative agent for men with psychogenic ED.
Sexuality
Cabergoline
Dopaminergics
Cabergoline.com
Caffeine and Parkinson's disease
Cabergoline as a neuroprotectant
Dopamine agonists for Parkinson's disease
Parkinsonian signs/symptoms in depressives
Cabergoline (Dostinex ) for Parkinson's disease
Cabergoline (Dostinex) v bromocriptine (Parlodel)
Carbergloine, dopamine and extracellular monoamine concentrations


Refs
and further reading

HOME
HedWeb
Nootropics
Cocaine.org
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family